Rebecca A. Kazin, MD, FAAD
SESSIONS
C005 Live Demonstration: The State of The Art of Aesthetic Dermatology
Mar 27, 2026
•
12:00 AM - 12:00 AM
•
Bluebird 1C
C011 Face Off: Evidence-Based Debates on Today’s Hottest Injectable Controversies
Mar 29, 2026
•
12:00 AM - 12:00 AM
•
Mile High 2A
DISCLOSURES
Allergan, Inc – Investigator(Grants/Research Funding), Stockholder(Stock); Galderma USA – Investigator(Grants/Research Funding), Speaker(Honoraria); Novaestiq Corp – Stockholder Private Company(Stock);